Emerging Biomarkers in Glioblastoma
Glioblastoma, the most common primary brain tumor, has few available therapies providing significant improvement in survival. Molecular signatures associated with tumor aggressiveness as well as with disease progression and their relation to differences in signaling pathways implicated in gliomagene...
Main Authors: | Warren P. Mason, Solmaz Sahebjam, Mairéad G. McNamara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/5/3/1103 |
Similar Items
-
Molecular heterogeneity in glioblastoma: potential clinical implications
by: Nicole Renee Parker, et al.
Published: (2015-03-01) -
Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?
by: Paulo Linhares, et al.
Published: (2020-08-01) -
The prognostic value of biomarkers in the evaluation of glioblastoma multiforme
by: Gascon, Marc-Andre
Published: (2018) -
Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
by: Xuejia Tang, et al.
Published: (2021-07-01) -
Biomarkers of Glioblastoma Multiforme
by: Guru Dutta Satyarthee, et al.
Published: (2018-09-01)